CasInvent Pharma

📍 Brno, Czechia🗓 Founded 2020👥 9 employees
Pharmaceutical Manufacturing🌐 casinvent.com
Website LinkedIn
The mission of CasInvent Pharma is to bring new therapeutic options for the treatment of selected leukemias to market. We are developing highly selective small molecule inhibitors of casein kinase I (CK1), and our main development program is focused on the identification of new drugs for the treatment of acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL). CasInvent Pharma was established in 2020 as a spin-off company of Masaryk University in cooperation with the investment partner i&i Prague.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was CasInvent Pharma founded?
CasInvent Pharma was founded in 2020.
What industry is CasInvent Pharma in?
CasInvent Pharma operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is CasInvent Pharma based?
CasInvent Pharma is headquartered in Brno, Czechia.